{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:39:17Z","timestamp":1787891957121,"version":"build-2784847793"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:00:00Z","timestamp":1629417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:00:00Z","timestamp":1629417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Melanoma cells rely on developmental programs during tumor initiation and progression. Here we show that the embryonic stem cell (ESC) factor Sall4 is re-expressed in the <jats:italic>Tyr::Nras<\/jats:italic><jats:sup><jats:italic>Q61K<\/jats:italic><\/jats:sup><jats:italic>; Cdkn2a<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup> melanoma model and that its expression is necessary for primary melanoma formation. Surprisingly, while Sall4 loss prevents tumor formation, it promotes micrometastases to distant organs in this melanoma-prone mouse model. Transcriptional profiling and in vitro assays using human melanoma cells demonstrate that SALL4 loss induces a phenotype switch and the acquisition of an invasive phenotype. We show that SALL4 negatively regulates invasiveness through interaction with the histone deacetylase (HDAC) 2 and direct co-binding to a set of invasiveness genes. Consequently, SALL4 knock down, as well as HDAC inhibition, promote the expression of an invasive signature, while inhibition of histone acetylation partially reverts the invasiveness program induced by SALL4 loss. Thus, SALL4 appears to regulate phenotype switching in melanoma through an HDAC2-mediated mechanism.<\/jats:p>","DOI":"10.1038\/s41467-021-25326-8","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T10:03:20Z","timestamp":1629453800000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7733-5904","authenticated-orcid":false,"given":"Johanna","family":"Diener","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2476-561X","authenticated-orcid":false,"given":"Arianna","family":"Baggiolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5528-3405","authenticated-orcid":false,"given":"Mattias","family":"Pernebrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Dalcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Lerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2940-006X","authenticated-orcid":false,"given":"Phil F.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Varum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"H\u00e4usel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4981-4107","authenticated-orcid":false,"given":"Salome","family":"Stierli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8751-1246","authenticated-orcid":false,"given":"Mathias","family":"Treier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0741-7987","authenticated-orcid":false,"given":"Lorenz","family":"Studer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Basler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell P.","family":"Levesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2279-6906","authenticated-orcid":false,"given":"Reinhard","family":"Dummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9894-2896","authenticated-orcid":false,"given":"Raffaella","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1547-5415","authenticated-orcid":false,"given":"Claudio","family":"Cant\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1143-7908","authenticated-orcid":false,"given":"Lukas","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,20]]},"reference":[{"key":"25326_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57\u201370 (2000).","journal-title":"Cell"},{"key":"25326_CR2","doi-asserted-by":"publisher","first-page":"e1007362","DOI":"10.1371\/journal.pgen.1007362","volume":"14","author":"A Nebbioso","year":"2018","unstructured":"Nebbioso, A., Tambaro, F. P., Dell\u2019Aversana, C. & Altucci, L. Cancer epigenetics: moving forward. PLoS Genet. 14, e1007362 (2018).","journal-title":"PLoS Genet."},{"key":"25326_CR3","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1126\/science.1230184","volume":"339","author":"ML Suv\u00e0","year":"2013","unstructured":"Suv\u00e0, M. L., Riggi, N. & Bernstein, B. E. Epigenetic reprogramming in cancer. Science 339, 1567\u20131570 (2013).","journal-title":"Science"},{"key":"25326_CR4","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.stemcr.2017.03.007","volume":"8","author":"M Bernhardt","year":"2017","unstructured":"Bernhardt, M. et al. Melanoma-derived iPCCs show differential tumorigenicity and therapy response. Stem Cell Rep. 8, 1379\u20131391 (2017).","journal-title":"Stem Cell Rep."},{"key":"25326_CR5","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nature13305","volume":"511","author":"S Boumahdi","year":"2014","unstructured":"Boumahdi, S. et al. SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma. Nature 511, 246\u2013250 (2014).","journal-title":"Nature"},{"key":"25326_CR6","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cell.2014.02.030","volume":"157","author":"ML Suv\u00e0","year":"2014","unstructured":"Suv\u00e0, M. L. et al. Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells. Cell 157, 580\u2013594 (2014).","journal-title":"Cell"},{"key":"25326_CR7","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1002\/stem.2406","volume":"34","author":"R Sato","year":"2016","unstructured":"Sato, R., Semba, T., Saya, H. & Arima, Y. Concise review: stem cells and epithelial-mesenchymal transition in cancer: biological implications and therapeutic targets. Stem Cells 34, 1997\u20132007 (2016).","journal-title":"Stem Cells"},{"key":"25326_CR8","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1158\/2159-8290.CD-17-1178","volume":"8","author":"A Mehta","year":"2018","unstructured":"Mehta, A. et al. Immunotherapy resistance by inflammation-induced dedifferentiation. Cancer Discov. 8, 935\u2013943 (2018).","journal-title":"Cancer Discov."},{"key":"25326_CR9","doi-asserted-by":"publisher","first-page":"9020","DOI":"10.1073\/pnas.1818210116","volume":"116","author":"A Miranda","year":"2019","unstructured":"Miranda, A. et al. Cancer stemness, intratumoral heterogeneity, and immune response across cancers. PNAS 116, 9020\u20139029 (2019).","journal-title":"PNAS"},{"key":"25326_CR10","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.cell.2018.06.025","volume":"174","author":"F Rambow","year":"2018","unstructured":"Rambow, F. et al. Toward minimal residual disease-directed therapy in melanoma. Cell 174, 843\u2013855.e19 (2018).","journal-title":"Cell"},{"key":"25326_CR11","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrc.2016.37","volume":"16","author":"AH Shain","year":"2016","unstructured":"Shain, A. H. & Bastian, B. C. From melanocytes to melanomas. Nat. Rev. Cancer 16, 345\u2013358 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"25326_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ydbio.2012.02.035","volume":"366","author":"E Dupin","year":"2012","unstructured":"Dupin, E. & Sommer, L. Neural crest progenitors and stem cells: from early development to adulthood. Dev. Biol. 366, 83\u201395 (2012).","journal-title":"Dev. Biol."},{"key":"25326_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nature09161","volume":"466","author":"AD Boiko","year":"2010","unstructured":"Boiko, A. D. et al. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 466, 133\u2013137 (2010).","journal-title":"Nature"},{"key":"25326_CR14","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ccr.2013.08.018","volume":"24","author":"J Caramel","year":"2013","unstructured":"Caramel, J. et al. A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. Cancer Cell 24, 466\u2013480 (2013).","journal-title":"Cancer Cell"},{"key":"25326_CR15","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1158\/0008-5472.CAN-10-3997","volume":"71","author":"G Civenni","year":"2011","unstructured":"Civenni, G. et al. Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Res. 71, 3098\u20133109 (2011).","journal-title":"Cancer Res."},{"key":"25326_CR16","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/sctm.20-0351","volume":"10","author":"J Diener","year":"2020","unstructured":"Diener, J. & Sommer, L. Reemergence of neural crest stem cell-like states in melanoma during disease progression and treatment. Stem Cells Transl. Med. 10, 522\u2013533 (2020).","journal-title":"Stem Cells Transl. Med."},{"key":"25326_CR17","doi-asserted-by":"crossref","unstructured":"Kaufman, C. K. et al. A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation. Science 351, (6272):aad2197 (2016).","DOI":"10.1126\/science.aad2197"},{"key":"25326_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000348418","volume":"198","author":"PM Kulesa","year":"2013","unstructured":"Kulesa, P. M., Morrison, J. A. & Bailey, C. M. The neural crest and cancer: a developmental spin on melanoma. Cells Tissues Organs 198, 12\u201321 (2013).","journal-title":"Cells Tissues Organs"},{"key":"25326_CR19","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.stem.2019.03.011","volume":"24","author":"S Varum","year":"2019","unstructured":"Varum, S. et al. Yin Yang 1 orchestrates a metabolic program required for both neural crest development and melanoma formation. Cell Stem Cell 24, 637\u2013653.e9 (2019).","journal-title":"Cell Stem Cell"},{"key":"25326_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-17739-8","volume":"11","author":"J Boshuizen","year":"2020","unstructured":"Boshuizen, J. et al. Reversal of pre-existing NGFR-driven tumor and immune therapy resistance. Nat. Commun. 11, 1\u201313 (2020).","journal-title":"Nat. Commun."},{"key":"25326_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nature11538","volume":"490","author":"J Landsberg","year":"2012","unstructured":"Landsberg, J. et al. Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation. Nature 490, 412\u2013416 (2012).","journal-title":"Nature"},{"key":"25326_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01573-6","volume":"8","author":"G Restivo","year":"2017","unstructured":"Restivo, G. et al. The low affinity neurotrophin receptor CD271 regulates phenotype switching in Melanoma. Nat. Commun. 8, 1988 (2017).","journal-title":"Nat. Commun."},{"key":"25326_CR23","doi-asserted-by":"publisher","first-page":"5937","DOI":"10.1158\/0008-5472.CAN-14-1174","volume":"74","author":"K Kemper","year":"2014","unstructured":"Kemper, K., De Goeje, P. L., Peeper, D. S. & Van Amerongen, R. Phenotype switching: tumor cell plasticity as a resistance mechanism and target for therapy. Cancer Res. 74, 5937\u20135941 (2014).","journal-title":"Cancer Res."},{"key":"25326_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/exd.12580","volume":"24","author":"NC Schlegel","year":"2015","unstructured":"Schlegel, N. C., von Planta, A., Widmer, D. S., Dummer, R. & Christofori, G. PI3K signalling is required for a TGF\u03b2-induced epithelial-mesenchymal-like transition (EMT-like) in human melanoma cells. Exp. Dermatol. 24, 22\u201328 (2015).","journal-title":"Exp. Dermatol."},{"key":"25326_CR25","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/ncb1481","volume":"8","author":"J Zhang","year":"2006","unstructured":"Zhang, J. et al. Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Nat. Cell Biol. 8, 1114\u20131123 (2006).","journal-title":"Nat. Cell Biol."},{"key":"25326_CR26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.gene.2016.02.019","volume":"584","author":"H Tatetsu","year":"2016","unstructured":"Tatetsu, H. et al. SALL4, the missing link between stem cells, development and cancer. Gene 584, 111\u2013119 (2016).","journal-title":"Gene"},{"key":"25326_CR27","first-page":"1171","volume":"369","author":"KJ Yong","year":"2013","unstructured":"Yong, K. J. et al. Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. N. Engl. J. Med. 369, 1171\u20131172 (2013).","journal-title":"N. Engl. J. Med."},{"key":"25326_CR28","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1182\/blood-2012-04-424275","volume":"121","author":"C Gao","year":"2013","unstructured":"Gao, C. et al. Targeting transcription factor SALL4 in acute myeloid leukemia by interrupting its interaction with an epigenetic complex. Blood 121, 1413\u20131421 (2013a).","journal-title":"Blood"},{"key":"25326_CR29","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/ncb2535","volume":"14","author":"O Shakhova","year":"2012","unstructured":"Shakhova, O. et al. Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma. Nat. Cell Biol. 14, 882\u2013890 (2012).","journal-title":"Nat. Cell Biol."},{"key":"25326_CR30","doi-asserted-by":"publisher","first-page":"e115717","DOI":"10.1371\/journal.pone.0115717","volume":"9","author":"P Reemann","year":"2014","unstructured":"Reemann, P. et al. Melanocytes in the skin\u2014-comparative whole transcriptome analysis of main skin cell types. PLoS ONE 9, e115717 (2014).","journal-title":"PLoS ONE"},{"key":"25326_CR31","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1158\/0008-5472.CAN-04-2970","volume":"65","author":"J Ackermann","year":"2005","unstructured":"Ackermann, J. et al. Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background. Cancer Res. 65, 4005\u20134011 (2005).","journal-title":"Cancer Res."},{"key":"25326_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0092-8674(00)81079-X","volume":"85","author":"M Serrano","year":"1996","unstructured":"Serrano, M. et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27\u201337 (1996).","journal-title":"Cell"},{"key":"25326_CR33","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/dvg.20205","volume":"44","author":"M Bosenberg","year":"2006","unstructured":"Bosenberg, M. et al. Characterization of melanocyte-specific inducible Cre recombinase transgenic mice. Genesis 44, 262\u2013267 (2006).","journal-title":"Genesis"},{"key":"25326_CR34","doi-asserted-by":"publisher","first-page":"16319","DOI":"10.1073\/pnas.0607884103","volume":"103","author":"U Elling","year":"2006","unstructured":"Elling, U., Klasen, C., Eisenberger, T., Anlag, K. & Treier, M. Murine inner cell mass-derived lineages depend on Sall4 function. PNAS 103, 16319\u201316324 (2006).","journal-title":"PNAS"},{"key":"25326_CR35","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/dvg.22003","volume":"50","author":"C Simon","year":"2012","unstructured":"Simon, C., Lickert, H., G\u00f6tz, M. & Dimou, L. Sox10-iCreER T2: a mouse line to inducibly trace the neural crest and oligodendrocyte lineage. Genesis 50, 506\u2013515 (2012).","journal-title":"Genesis"},{"key":"25326_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1423-0127-20-6","volume":"20","author":"MM Forghanifard","year":"2013","unstructured":"Forghanifard, M. M. et al. Role of SALL4 in the progression and metastasis of colorectal cancer. J. Biomed. Sci. 20, 6 (2013).","journal-title":"J. Biomed. Sci."},{"key":"25326_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-016-0378-z","volume":"35","author":"J He","year":"2016","unstructured":"He, J. et al. Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt\/\u03b2-catenin pathway in esophageal squamous cell carcinoma. J. Exp. Clin. Cancer Res. 35, 1\u201313 (2016).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"25326_CR38","first-page":"1","volume":"10","author":"L Liu","year":"2015","unstructured":"Liu, L. et al. SALL4 as an epithelial-mesenchymal transition and drug resistance inducer through the regulation of c-Myc in endometrial cancer. PLoS ONE 10, 1\u201315 (2015).","journal-title":"PLoS ONE"},{"key":"25326_CR39","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"25326_CR40","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1158\/0008-5472.CAN-07-2491","volume":"68","author":"KS Hoek","year":"2008","unstructured":"Hoek, K. S. et al. In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res. 68, 650\u2013656 (2008).","journal-title":"Cancer Res."},{"key":"25326_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7683","volume":"6","author":"A Verfaillie","year":"2015","unstructured":"Verfaillie, A. et al. Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. Nat. Commun. 6, 6683 (2015).","journal-title":"Nat. Commun."},{"key":"25326_CR42","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189\u2013196 (2016).","journal-title":"Science"},{"key":"25326_CR43","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1111\/j.1537-2995.2012.03888.x","volume":"53","author":"C Gao","year":"2013","unstructured":"Gao, C. et al. SALL4 is a key transcription regulator in normal human hematopoiesis. Transfusion 53, 1037\u20131049 (2013b).","journal-title":"Transfusion"},{"key":"25326_CR44","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1111\/febs.12972","volume":"282","author":"SL Kloet","year":"2015","unstructured":"Kloet, S. L. et al. Towards elucidating the stability, dynamics and architecture of the nucleosome remodeling and deacetylase complex by using quantitative interaction proteomics. FEBS J. 282, 1774\u20131785 (2015).","journal-title":"FEBS J."},{"key":"25326_CR45","doi-asserted-by":"publisher","first-page":"e5577","DOI":"10.1371\/journal.pone.0005577","volume":"4","author":"J Lu","year":"2009","unstructured":"Lu, J. et al. Stem cell factor SALL4 represses the transcriptions of PTEN and SALL1 through an epigenetic repressor complex. PLoS ONE 4, e5577 (2009).","journal-title":"PLoS ONE"},{"key":"25326_CR46","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1101\/gad.13.15.1924","volume":"13","author":"Y Zhang","year":"1999","unstructured":"Zhang, Y. et al. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev. 13, 1924\u20131935 (1999).","journal-title":"Genes Dev."},{"key":"25326_CR47","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1158\/0008-5472.CAN-15-2680","volume":"76","author":"A Krumm","year":"2016","unstructured":"Krumm, A. et al. Enhanced histone deacetylase activity in malignant melanoma provokes RAD51 and FANCD2-triggered drug resistance. Cancer Res. 76, 3067\u20133077 (2016).","journal-title":"Cancer Res."},{"key":"25326_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pgen.1004877","volume":"11","author":"O Shakhova","year":"2015","unstructured":"Shakhova, O. et al. Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma. PLoS Genet. 11, 1\u201321 (2015).","journal-title":"PLoS Genet."},{"key":"25326_CR49","doi-asserted-by":"publisher","first-page":"e120422","DOI":"10.1172\/jci.insight.120422","volume":"3","author":"O Giricz","year":"2018","unstructured":"Giricz, O. et al. The RUNX1\/IL-34\/CSF-1R axis is an autocrinally regulated modulator of resistance to BRAF-V600E inhibition in melanoma. JCI Insight 3, e120422 (2018).","journal-title":"JCI Insight"},{"key":"25326_CR50","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nn1631","volume":"9","author":"F Marmig\u00e8re","year":"2006","unstructured":"Marmig\u00e8re, F. et al. The Runx1\/AML1 transcription factor selectively regulates development and survival of TrkA nociceptive sensory neurons. Nat. Neurosci. 9, 180\u2013187 (2006).","journal-title":"Nat. Neurosci."},{"key":"25326_CR51","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1242\/dev.106567","volume":"142","author":"RL Mort","year":"2015","unstructured":"Mort, R. L., Jackson, I. J. & Elizabeth Patton, E. The melanocyte lineage in development and disease. Development 142, 620\u2013632 (2015).","journal-title":"Development"},{"key":"25326_CR52","doi-asserted-by":"publisher","first-page":"e73953","DOI":"10.1371\/journal.pone.0073953","volume":"8","author":"G Lal","year":"2013","unstructured":"Lal, G. et al. Human Melanoma cells over-express extracellular matrix 1 (ECM1) which is regulated by TFAP2C. PloS ONE 8, e73953 (2013).","journal-title":"PloS ONE"},{"key":"25326_CR53","doi-asserted-by":"publisher","first-page":"e1006636","DOI":"10.1371\/journal.pgen.1006636","volume":"13","author":"HE Seberg","year":"2017","unstructured":"Seberg, H. E. et al. TFAP2 paralogs regulate melanocyte differentiation in parallel with MITF. PLoS Genet. 13, e1006636 (2017).","journal-title":"PLoS Genet."},{"key":"25326_CR54","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1101\/gad.5.1.105","volume":"5","author":"PJ Mitchell","year":"1991","unstructured":"Mitchell, P. J., Timmons, P. M., H\u00e9bert, J. M., Rigby, P. W. J. & Tjian, R. Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Dev. 5, 105\u2013119 (1991).","journal-title":"Genes Dev."},{"key":"25326_CR55","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/381238a0","volume":"381","author":"J Zhang","year":"1996","unstructured":"Zhang, J. et al. Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature 381, 238\u2013241 (1996).","journal-title":"Nature"},{"key":"25326_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-016-2693-3","volume":"16","author":"M D\u00edaz-N\u00fa\u00f1ez","year":"2016","unstructured":"D\u00edaz-N\u00fa\u00f1ez, M. et al. Histone deacetylase inhibitors induce invasion of human melanoma cells in vitro via differential regulation of N-cadherin expression and RhoA activity. BMC Cancer 16, 1\u201312 (2016).","journal-title":"BMC Cancer"},{"key":"25326_CR57","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.bbamcr.2012.12.002","volume":"1833","author":"GM Jiang","year":"2013","unstructured":"Jiang, G. M. et al. Histone deacetylase inhibitor induction of epithelial-mesenchymal transitions via up-regulation of Snail facilitates cancer progression. Biochim. Biophys. Acta 1833, 663\u2013671 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"25326_CR58","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/38664","volume":"389","author":"M Grunstein","year":"1997","unstructured":"Grunstein, M. Histone acetylation in chromatin structure and transcription. Nature 389, 349\u2013352 (1997).","journal-title":"Nature"},{"key":"25326_CR59","doi-asserted-by":"publisher","first-page":"a018713","DOI":"10.1101\/cshperspect.a018713","volume":"6","author":"E Seto","year":"2014","unstructured":"Seto, E. & Yoshida, M. Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb. Perspect. Biol. 6, a018713 (2014).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"25326_CR60","doi-asserted-by":"publisher","first-page":"108574","DOI":"10.1016\/j.celrep.2020.108574","volume":"34","author":"NR Kong","year":"2021","unstructured":"Kong, N. R. et al. Zinc finger protein SALL4 functions through an AT-rich motif to regulate gene expression. Cell Rep. 34, 108574 (2021).","journal-title":"Cell Rep."},{"key":"25326_CR61","first-page":"3074","volume":"143","author":"A Miller","year":"2016","unstructured":"Miller, A. et al. Sall4 controls differentiation of pluripotent cells independently of the nucleosome remodelling and deacetylation (NuRD) complex. Development 143, 3074\u20133084 (2016).","journal-title":"Development"},{"key":"25326_CR62","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1006\/geno.1996.0631","volume":"38","author":"J\u00fcrgen Kohlhase","year":"1996","unstructured":"Kohlhase, J. \u00fcrgen et al. Isolation, characterization, and organ-specific expression of two novel human zinc finger genes related to the Drosophila gene spalt. Genomics 38, 291\u2013298 (1996).","journal-title":"Genomics"},{"key":"25326_CR63","first-page":"1","volume":"5","author":"J Yang","year":"2010","unstructured":"Yang, J., Gao, C., Chai, L. & Ma, Y. A novel SALL4\/OCT4 transcriptional feedback network for pluripotency of embryonic stem cells. PLoS ONE 5, 1\u201310 (2010).","journal-title":"PLoS ONE"},{"key":"25326_CR64","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1159\/000071048","volume":"98","author":"J Kohlhase","year":"2002","unstructured":"Kohlhase, J. et al. Cloning and expression analysis of Sall4, the murine homologue of the gene mutated in Okihiro syndrome. Cytogenet. Genome Res. 98, 274\u2013277 (2002).","journal-title":"Cytogenet. Genome Res."},{"key":"25326_CR65","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3390\/ijms18071414","volume":"18","author":"T Eckschlager","year":"2017","unstructured":"Eckschlager, T., Plch, J., Stiborova, M. & Hrabeta, J. Histone deacetylase inhibitors as anticancer drugs. Int. J. Mol. Sci. 18, 1414 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"25326_CR66","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/exd.13089","volume":"25","author":"E Hornig","year":"2016","unstructured":"Hornig, E., Heppt, M. V., Graf, S. A., Ruzicka, T. & Berking, C. Inhibition of histone deacetylases in melanoma\u2014a perspective from bench to bedside. Exp. Dermatol. 25, 831\u2013838 (2016).","journal-title":"Exp. Dermatol."},{"key":"25326_CR67","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1158\/2159-8290.CD-18-0879","volume":"9","author":"O Maertens","year":"2019","unstructured":"Maertens, O. et al. MAPK pathway suppression unmasks latent dna repair defects and confers a chemical synthetic vulnerability in BRAF-, NRAS-, and NF1 -mutant melanomas. Cancer Discov. 9, 526\u2013545 (2019).","journal-title":"Cancer Discov."},{"key":"25326_CR68","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1242\/dev.098855","volume":"141","author":"DA Ridenour","year":"2014","unstructured":"Ridenour, D. A. et al. The neural crest cell cycle is related to phases of migration in the head. Development 141, 1095\u20131103 (2014).","journal-title":"Development"},{"key":"25326_CR69","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/PAI.0b013e318279bc0a","volume":"21","author":"A Mohamed","year":"2013","unstructured":"Mohamed, A., Gonzalez, R. S., Lawson, D., Wang, J. & Cohen, C. SOX10 expression in malignant melanoma, carcinoma, and normal tissues. Appl. Immunohistochem. Mol. Morphol. 21, 506\u2013510 (2013).","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"25326_CR70","doi-asserted-by":"publisher","first-page":"21901","DOI":"10.1074\/jbc.M115.670976","volume":"290","author":"JD Kubic","year":"2015","unstructured":"Kubic, J. D. et al. PAX3 and FOXD3 promote CXCR4 expression in melanoma. J. Biol. Chem. 290, 21901\u201321914 (2015).","journal-title":"J. Biol. Chem."},{"key":"25326_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0594-4","volume":"16","author":"PF Cheng","year":"2015","unstructured":"Cheng, P. F. et al. Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma. Genome Biol. 16, 42 (2015).","journal-title":"Genome Biol."},{"key":"25326_CR72","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/exd.12683","volume":"24","author":"MIG Raaijmakers","year":"2015","unstructured":"Raaijmakers, M. I. G. et al. A new live-cell biobank workflow efficiently recovers heterogeneous melanoma cells from native biopsies. Exp. Dermatol. 24, 377\u2013380 (2015).","journal-title":"Exp. Dermatol."},{"key":"25326_CR73","doi-asserted-by":"publisher","first-page":"6991","DOI":"10.1074\/jbc.M113.511444","volume":"289","author":"P Kumar","year":"2014","unstructured":"Kumar, P., Tripathi, S. & Pandey, K. N. Histone deacetylase inhibitors modulate the transcriptional regulation of guanylyl cyclase\/natriuretic peptide receptor-a gene: interactive roles of modified histones, histone acetyltransferase, p300, and Sp1. J. Biol. Chem. 289, 6991\u20137002 (2014).","journal-title":"J. Biol. Chem."},{"key":"25326_CR74","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3324\/haematol.2009.015495","volume":"95","author":"EM Ocio","year":"2010","unstructured":"Ocio, E. M. et al. In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma. Haematologica 95, 794\u2013803 (2010).","journal-title":"Haematologica"},{"key":"25326_CR75","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/CMR.0b013e328364c0ed","volume":"23","author":"DM Woods","year":"2013","unstructured":"Woods, D. M. et al. The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity. Melanoma Res. 23, 341\u2013348 (2013).","journal-title":"Melanoma Res."},{"key":"25326_CR76","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ccell.2018.06.001","volume":"34","author":"D Zingg","year":"2018","unstructured":"Zingg, D. et al. EZH2-mediated primary cilium deconstruction drives metastatic melanoma formation. Cancer Cell 34, 69\u201384.e14 (2018).","journal-title":"Cancer Cell"},{"key":"25326_CR77","doi-asserted-by":"publisher","first-page":"e46314","DOI":"10.7554\/eLife.46314","volume":"8","author":"MP Meers","year":"2019","unstructured":"Meers, M. P., Bryson, T. D., Henikoff, J. G. & Henikoff, S. Improved CUT&RUN chromatin profiling tools. eLife 8, e46314 (2019a).","journal-title":"eLife"},{"key":"25326_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2009-10-3-r25","volume":"10","author":"B Langmead","year":"2009","unstructured":"Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).","journal-title":"Genome Biol."},{"key":"25326_CR79","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The Sequence Alignment\/Map (SAM) Format and SAMtools 1000 Genome Project Data Processing Subgroup. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"25326_CR80","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13072-019-0287-4","volume":"12","author":"MP Meers","year":"2019","unstructured":"Meers, M. P., Tenenbaum, D. & Henikoff, S. Peak calling by Sparse Enrichment Analysis for CUT&RUN chromatin profiling. Epigenet. Chromatin 12, 42 (2019b).","journal-title":"Epigenet. Chromatin"},{"key":"25326_CR81","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.15252\/embr.201744330","volume":"18","author":"S Leone","year":"2017","unstructured":"Leone, S., B\u00e4r, D., Slabber, C. F., Dalcher, D. & Santoro, R. The RNA helicase DHX9 establishes nucleolar heterochromatin, and this activity is required for embryonic stem cell differentiation. EMBO Rep. 18, 1248\u20131262 (2017).","journal-title":"EMBO Rep."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25326-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25326-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25326-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T19:05:46Z","timestamp":1675623946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25326-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,20]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["25326"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-25326-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,20]]},"assertion":[{"value":"24 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5056"}}